Form of Proxy

Approval of the parent company financial statements for the fiscal year ended December 31, 2025

Approval of the consolidated financial statements for the fiscal year ended December 31, 2025

Appropriation of net profit – determination of dividend

Approval of related-party agreements

Renewal of Bernard Arnault’s term of office as a Director

Renewal of Antoine Arnault’s term of office as a Director

Renewal of Maria Luisa Loro Piana’s term of office as a Director

Approval of the information on the compensation of executive officers referred to in section I of Article L. 22-10-9 I of the French Commercial Code

Approval of the items of compensation paid during fiscal year 2025 and awarded in respect of that year to the Chairman of the Board of Directors, Bernard Arnault

Approval of the items of compensation paid during fiscal year 2025 and awarded in respect of that year to the Chief Executive Office, Antoine Arnault

Approval of the compensation policy for Directors

Approval of the compensation policy for the Chairman of the Board of Directors

Approval of the compensation policy for the Chief Executive Officer

Authorization to be granted to the Board of Directors, for a period of eighteen months, to trade in the Company’s shares for a maximum purchase price of 1,200 euros per share, thus a maximum cumulative amount of 21.7 billion euros

Authorization to be granted to the Board of Directors, for a period of eighteen months, to reduce the share capital by retiring Company’s shares acquired under Article L. 22-10-62

Delegation of authority to be granted to the Board of Directors, for a period of twenty-six months, to increase the share capital through the capitalization of profits, reserves, additional paid-in capital or other items

Delegation of authority to the Board of Directors, for a period of 26 months, to increase the share capital, with preferential subscription rights maintained, through the issuance of ordinary shares and/or equity securities (which may, where applicable, grant access to other equity securities to be issued) and/or securities granting access to equit

Delegation of authority to be granted to the Board of Directors, for a period of 26 months, to issue, by means of a public offering (not covered by section 1 of Article L. 411-2 of the French Monetary and Financial Code (Code montaire et financier)), ordinary shares and/or equity securities giving access to other equity securities or that confer ri

Delegation of authority to be granted to the Board of Directors, for a period of twenty-six months, to issue ordinary shares and/or securities giving access to other equity securities or that confer rights to the allocation of debt securities, and/or securities giving access to equity securities to be issued, without preferential subscription right

Delegation of authority to be granted to the Board of Directors, for a period of twenty-six months, to raise the number of securities to be issued in connection with capital increases, either with or without preferential subscription rights for shareholders, by exercising overallotment options in the event that the securities on offer are oversubsc

Delegation of authority to be granted to the Board of Directors, for a period of twenty-six months, to issue shares and/or equity securities giving access to other equity securities or that confer rights to the allocation of debt securities in consideration for securities tendered to any public exchange offer initiated by the Company

Delegation of authority to be granted to the Board of Directors, for a period of 26 months, to issue ordinary shares and/or equity securities giving access to other equity securities of the Company or that confer rights to the allocation of debt securities in consideration for the contributions in kind to the Company of equity securities or other s

Authorization to be granted to the Board of Directors, for a period of twenty-six months, to grant subscription options without preferential subscription rights for shareholders or share purchase options to employees and/or senior executive officers of the Company and related entities, up to a maximum of 1% of the share capital

Authorization to be granted to the Board of Directors for a twenty-six-month period to award bonus shares to be issued with the removal of preferential subscription rights, or shares in issue for the benefit of employees and/or senior executive officers of the Company and related entities up to a limit of 1% of the share capital

Delegation of authority to be granted to the Board of Directors, for a period of twenty-six months, to issue shares and/or securities giving access to the Company’s share capital without preferential subscription rights for shareholders, reserved for members of the savings plans (PEEs), up to a maximum of 1% of the share capital

Delegation of authority to be granted to the Board of Directors, for a period of 18 months, to carry out capital increases, without preferential subscription rights for shareholders, reserved for categories of beneficiaries comprising eligible employees and executive officers of foreign subsidiaries, up to a maximum of 1% of the share capital

Determination of the overall limit for capital increases to be carried out immediately or at a future date pursuant to delegations of authority